The conolidine Diaries
These final results, along with a former report showing that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like habits in mice,2 help the concept of targeting ACKR3 as a singular approach to modulate the opioid procedure, which could open up new therapeutic avenues for opioid-associated Issues.These outcomes counsel that conolidine is